Aldosterone-Producing Adrenocortical Carcinoma with Co-Secretion of Cortisol and Estradiol: A Case Report
Keywords:
adrenal cancer, adrenocortical carcinoma, hyperaldosteronism, hypertensionAbstract
Aldosterone-producing adrenocortical carcinoma comprises less than 7% of all functioning adrenocortical carcinomas. We report a rare case of adrenocortical carcinoma with a clinical picture of primary aldosteronism and subclinical Cushing’s syndrome and feminization. Complete surgical resection normalized blood pressures and aldosterone, cortisol and estradiol levels. Long-term monitoring is recommended with imaging and hormonal evaluation used as tumor markers for recurrence.
Downloads
References
United States. National Cancer Institute. Biometry Branch, Young JL, Cutler SJ, Connelly RR. Third national cancer survey: Incidence data. Bethesda, Md. : US Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, 1975.
Ng L, Libertino JM. Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol. 2003;169(1):5–11. PMID: 12478091. https://doi.org/10.1097/01.ju.0000030148.59051.35.
Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP. Aldosterone-producing adrenocortical carcinoma: An unusual cause of Conn’s syndrome with an ominous clinical course. Endocr Relat Cancer. 2005;12(1):149–59. PMID: 15788646. https://doi.org/10.1677/erc.1.00867.
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5): 1889-916. PMID: 26934393. https://doi.org/10.1210/jc.2015-4061.
Young WF Jr. Endocrine Hypertension. William's Endocrinology, 13th edition. Chapter 16. http://medical.iauyazd.ac.ir/files/MEDICINE/Endocrinology/Williams%20Textbook%20of%20Endocrinology%20%202016/16%20Endocrine%20Hypertension.pdf.
Fassnacht M, Kroiss M, Allolio B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98(12):4551–64. PMID: 24081734. https://doi.org/10.1210/jc.2013-3020.
Allolio B, Fassnacht M. Clinical review: Adrenocortical Carcinoma: Clinical Update. J Clin Endocrinol Metab. 2006; 91(6):2027-37. PMID: 16551738. https://doi.org/10.1210/jc.2005-2639.
Berruti A, Baudin E, Gelderblom H, et al. Adrenal cancer: ESMO Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 (Suppl 7): vii131–8. PMID: 22997446. https://doi.org/10.1093/annonc/mds231.
Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13(3):202–6. PMID: 2919718.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.